Evidence map›Paper›PMID 31416289›Full record

ArticleCells2019

Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.

Qi He, Zhenyu Li, Changchang Meng, Jingxian Wu, Yong Zhao, Jing Zhao

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 115 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. TargetingJournal of pharmaceutical analysis · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8Apoptosis : an international journal on programmed cell death · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qi HeDepartment of Pathophysiology, Chongqing Medical University, Chongqing 400010, China.
Zhenyu LiInstitute of Neuroscience, Chongqing Medical University, Chongqing 400010, China.
Changchang MengDepartment of Pathophysiology, Chongqing Medical University, Chongqing 400010, China.
Jingxian WuInstitute of Neuroscience, Chongqing Medical University, Chongqing 400010, China.
Yong ZhaoInstitute of Neuroscience, Chongqing Medical University, Chongqing 400010, China. zhaoyong668@cqmu.edu.cn.
Jing ZhaoDepartment of Pathophysiology, Chongqing Medical University, Chongqing 400010, China. zhaojing@cqmu.edu.cn.
Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNod-like receptor protein 3 (NLRP3) inflammasome is a crucial contributor in the inflammatory process during cerebral ischemia/reperfusion (I/R) injury. ATF4 plays a pivotal role in the pathogenesis of cerebral I/R injury, however, its function and underlying mechanism are not fully characterized yet. In the current study, we examined whether ATF4 ameliorates cerebral I/R injury by inhibiting NLRP3 inflammasome activation and whether mitophagy is involved in this process. In addition, we explored the role of parkin in ATF4-mediated protective effects.

Indexed as

MitophagyActivating Transcription Factor 4AnimalsBrain IschemiaInflammasomesMaleMitochondriaNLR Family, Pyrin Domain-Containing 3 ProteinRatsRats, Sprague-DawleyReperfusion InjuryUbiquitin-Protein LigasesActivating Transcription Factor 4Atf4 protein, ratInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratparkin proteinUbiquitin-Protein LigasesATF4ischemia-reperfusionmitophagyneuroprotectionNLRP3 inflammasomeParkin

Identifiers

PMID31416289
PMCPMC6721752
OpenAlexW2967134419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.